Preformed and De Novo Donor Specific Antibodies in Visceral Transplantation: Long-Term Outcome With Special Reference to the Liver
Open Access
- 4 September 2012
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 12 (11) , 3047-3060
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Mechanisms of Rejection: Current PerspectivesTransplantation, 2012
- Current Status of Pediatric Intestinal Failure, Rehabilitation, and Transplantation: Summary of a ColloquiumTransplantation, 2011
- Stromal Cell-Based Immunotherapy in TransplantationImmunotherapy, 2011
- The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver TransplantationAmerican Journal of Transplantation, 2011
- Pre- and posttransplantation allosensitization in heart allograft recipients: Major impact of de novo alloantibody production on allograft survivalHuman Immunology, 2011
- De Novo Donor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft FailureAmerican Journal of Transplantation, 2009
- Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant FailureAmerican Journal of Transplantation, 2009
- Clinical significance of anti-HLA antibodies detected by Luminex®: Enhancing the interpretation of CDC-BXM and important post-transplantation monitoring toolsHuman Immunology, 2009
- Platelets Influence Vascularized Organ Transplants from Start to FinishAmerican Journal of Transplantation, 2008
- Preformed Cytotoxic Antibodies in Potential Allograft Recipients: Recent DataHuman Immunology, 2005